| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 15, 2005
Accepted on July 28, 2005
Department of Bacteriology and Third Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki, Japan
* To whom correspondence should be addressed. E-mail: a27k03n0{at}cc.hirosaki-u.ac.jp.
Previous studies have showed that CRF modulates immune response during inflammation. We investigated the effect of CRF family peptides on host resistance to Listeria monocytogenes infection in mice. When mice were administered ip with CRF, urocortin (Ucn) or Ucn2 30 min prior a sublethal infection with Listeria monocytogenes, the numbers of bacteria in the organs of Ucn2-treated mice were dramatically increased and most of these mice succumbed. However, host resistance to the infection was retained in CRF- or Ucn-treated mice. The suppressive effect of Ucn2 was dependent on CRF receptor type 2 because an antagonist to the receptor canceled the effect of Ucn2. IL-10 production was significantly increased and
interferon (IFN-
) and TNF-
production was decreased in the spleens of Ucn2-treated mice compared with those in Ucn2-untreated control mice. The effect of Ucn2 was canceled by treatment with anti-IL-10 monoclonal antibody and in IL-10 deficient mice. The expression and activation of signal transducers and activators of transcription 3 (STAT3) were up-regulated and the expression and activation of STAT1 were down-regulated in the spleens from Ucn2-treated mice compared with vehicle-treated mice. Moreover, suppression of TNF-
production and augmentation of IL-10 production and expression and activation of STAT3 by Ucn2 treatment were observed in heat-killed L. monocytogenes-stimulated macrophages. These results suggested that Urn2 suppresses host resistance to L. monocytogenes infection via up-regulation of IL-10 production.
This article has been cited by other articles:
![]() |
A. C Moss, P. Anton, T. Savidge, P. Newman, A. S Cheifetz, J. Gay, S. Paraschos, M. W. Winter, M. P Moyer, K. Karalis, et al. Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2{alpha} Gut, September 1, 2007; 56(9): 1210 - 1217. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kokkotou, D. Torres, A. C. Moss, M. O'Brien, D. E. Grigoriadis, K. Karalis, and C. Pothoulakis Corticotropin-releasing hormone receptor 2-deficient mice have reduced intestinal inflammatory responses. J. Immunol., September 1, 2006; 177(5): 3355 - 3361. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Moffatt, R. Lever, and C. P. Page Activation of corticotropin-releasing factor receptor-2 causes bronchorelaxation and inhibits pulmonary inflammation in mice FASEB J, September 1, 2006; 20(11): 1877 - 1879. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |